Advertisement
Advertisement
Manhattan Scientifics, Inc. (MHTX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:43PM EDT
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0115 |
| Open | 0.0101 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0101 - 0.0129 |
| 52 Week Range | 0.0100 - 0.0385 |
| Volume | |
| Avg. Volume | 77,190 |
| Market Cap | 7.215M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Manhattan Scientifics Announces Early Results from Cancer Company
NEW YORK, March 17, 2022--Manhattan Scientifics Inc. (OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.
- Business Wire
Manhattan Scientifics Cancer Imaging Asset Announces Progress on Australian Clinical Study
NEW YORK, November 01, 2021--Manhattan Scientifics Inc. (OTC: QB), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. (IBX.AX).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
